5:50 PM
 | 
Jul 18, 2005
 |  BC Extra  |  Company News

FDA panel wants more AlzheimAlert data

Nymox (NYMX) said that on Friday an FDA panel voted 5-2 against approval of a kit version of AlzheimAlert...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >